AptaBio Therapeutics Inc. (KOSDAQ:293780)
7,700.00
-240.00 (-3.02%)
At close: Feb 6, 2026
6.94% (1Y)
| Market Cap | 216.32B +15.5% |
| Revenue (ttm) | 3.44B +18.4% |
| Net Income | -20.23B |
| EPS | -804.26 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 179,060 |
| Average Volume | 201,097 |
| Open | 7,720.00 |
| Previous Close | 7,940.00 |
| Day's Range | 7,500.00 - 7,800.00 |
| 52-Week Range | 6,610.00 - 11,960.00 |
| Beta | 1.04 |
| RSI | 38.96 |
| Earnings Date | Aug 14, 2025 |